Genomic newborn screening: public health policy considerations and recommendations.

Main|Search|PHGKB

From Guideline Database

This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.

---

• Genomic newborn screening: public health policy considerations and recommendations.  
  Published 2017 ( Global Alliance for Genomics and Health's Regulatory and Ethics Working Group)
• Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.  
  Published 2014 ( Clinical Pharmacogenetics Implementation Consortium (CPIC))
• Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.  
  Published 2014 ( Clinical Pharmacogenetics Implementation Consortium (CPIC))
• Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.  
  Published 2013 ( Clinical Pharmacogenetics Implementation Consortium (CPIC))
• Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.  
  Published 2015 ( European Society of Human Genetics (ESHG)) ( American Society of Human Genetics (ASHG))

more